Oncology & Cancer

Combination immunotherapy effective for advanced prostate cancer

Advanced prostate cancer resistant to castration therapy appears to respond well to a combination of immune checkpoint blockades and treatments that target certain immune-busting cells commonly associated with poor patient ...

Diseases, Conditions, Syndromes

Drug combination defeats dengue, Ebola in mice, study finds

A combination of two cancer drugs inhibited both dengue and Ebola virus infections in mice in a study led by Stanford University School of Medicine researchers, despite the fact that these two viruses are vastly different ...

Diseases, Conditions, Syndromes

First drug-resistant malaria parasite detected in Africa

For the first time in Africa, researchers said Wednesday they have detected a malaria parasite that is partially resistant to the top anti-malaria drug, artemisinin, raising concern about efforts to fight a disease that ...

HIV & AIDS

Progress toward HIV cure highlighted

A comprehensive collection of articles describing the broad scope and current status of this global effort is published in a special issue of AIDS Research and Human Retroviruses.

Oncology & Cancer

The best treatment for laryngeal cancer? This approach helps decide

Even as treatment options for laryngeal cancer seemed to improve, survival rates did not. For the most advanced patients, 50 percent survival was the norm, whether patients had surgery to totally remove the voice box or alternative ...

Oncology & Cancer

Paving the way for research on combination therapies

Patients have long benefited from combination treatments—whether combining surgery with chemotherapy and radiation, or combining chemotherapy agents in succession. Building on the logic that attacking cancer from multiple ...

page 37 from 40